Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernovartis.com
English RSS Feed
Get the latest updates from English RSS Feed directly as they happen.
Follow now 131 followers
Latest posts
Last updated 12 days ago
Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the company
13 days ago
Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires...
Novartis verzeichnet ein starkes zweites Quartal mit zweistelligem Umsatzwachstum und erhöhter Kerngewinnmarge; Prognose für das operative Kernergebnis im Geschäftsjahr 2025 angehoben
13 days ago
Novartis verzeichnet ein starkes zweites Quartal mit zweistelligem Umsatzwachstum und erhöhter Kerngewinnmarge...
Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
13 days ago
Novartis reports strong Q2 with double-digit sales growth and core margin expansion...
Novartis receives approval for first malaria medicine for newborn babies and young infants
22 days ago
Novartis receives approval for first malaria medicine for newborn babies and young...
Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)
27 days ago
Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant...
Novartis completes acquisition of Regulus Therapeutics
about 1 month ago
Novartis completes acquisition of Regulus Therapeutics arcticnovartis Wed, 06/25/2025 - 15:19 Read...
Novartis announces expiration of Regulus Therapeutics tender offer
about 1 month ago
Novartis announces expiration of Regulus Therapeutics tender offer arcticnovartis Wed, 06/25/2025 -...
Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer
about 1 month ago
Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer...
Novartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in new population of patients with PNH
about 2 months ago
Novartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in...
Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
about 2 months ago
Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients...
Novartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis
about 2 months ago
Novartis Kisqali® reduces risk of recurrence in younger patients with early breast...
Novartis announces commencement of tender offer to acquire Regulus Therapeutics
2 months ago
Novartis announces commencement of tender offer to acquire Regulus Therapeutics arcticnovartis Tue...